Pharmacyclics llc - Company & Market Research Reports

Pharmacyclics LLC focuses on developing novel therapies for the treatment of cancer and immune-mediated diseases in the United States. The company markets IMBRUVICA, a single-agent therapy used for the treatment of patients with chronic lymphocytic leukemia, mantle cell lymphoma and waldenström's macroglobulinemia. It also has several product candidates in clinical development. The company was founded in 1991 and is headquartered in Sunnyvale, California.

From
From
From
From
From
From
Hematological Tumor - Pipeline Review, H1 2014 - Product Thumbnail Image

Hematological Tumor - Pipeline Review, H1 2014

  • Drug Pipelines
  • 450 Pages
From
From
From
From
From
Follicular Lymphoma - Pipeline Review, H2 2016 - Product Thumbnail Image

Follicular Lymphoma - Pipeline Review, H2 2016

  • Drug Pipelines
  • 540 Pages
From
From
From
From
From
From
From
Loading Indicator
adroll